The Edinburgh surgical statistics (audit) have been analysed for the years 1959, 1964, 1969, 1974, and 1979 to determine the trends in pulmonary embolism in surgical patients who died. There was a total of 61 038 operations, 1528 postoperative deaths, 804 necropsies, and 158 reported pulmonary emboli. The incidence of embolism diagnosed clinically and at necropsy fell throughout the period. This fall held good after corrections for necropsy rates, prognosis, and proportions of major operations.
Introduction Pulmonary embolism has been described as the commonest acute lung disorder in hospital patients.' The Registrar General's figures for England and Wales2 and for Scotland3 have shown substantial increases in incidence over the past 50 years. Much of the research effort and expenditure devoted to this subject in recent years has been prompted by awareness of these trends. To To determine whether trends in embolism were influenced by changes in the relative severity of the operations, the latter were divided into "major" and "minor." Major operations included all intra-abdominal or thoracoabdominal procedures, nephrectomy, cystectomy, prostatectomy, mastectomy, repair of incisional hernia, vascular grafts, endarterectomies, and amputation.
Results
The overall statistics are presented in the was an incidental finding. Further analysis is therefore confined to the necropsy-proved group. What were the trends when their various corrections were made? Figure 2 shows the trends in necropsy-proved embolism in patients with a good prognosis, expressed as per 100 major operations. There was a fall from 0 5% to 0-15% per 100. When we looked at the types of patients dying of pulmonary embolism a change was apparent. 
Discussion
The standardised method of setting out their reports adopted by the surgeons over the years has in part offset some of the difficulties and disadvantages of retrospective analysis.
It is well known that the frequency with which pulmonary embolism is reported is proportional to the diligence with which it is sought. In most patients it is an occult disease since most emboli are small and do not cause infarction. As for postmortem examination there is no doubt that painstaking search along the ramifications of the pulmonary arterial tree and serial sections through the lung will find emboli much in excess of the numbers reported here.5 These limitations on our data are fully accepted.
We were, however, concerned particularly with pulmonary embolism as a cause of death in surgical patients who ought, on other grounds, to thrombosis give rise to clinically recognisable symptoms in the legs beforehand. 6 We therefore believe that we have shown a real trend. In the first 15 years of the study (1959-74) the percentage of emboli per necropsy did not fall. Therefore the fall must have reflected the improving operative mortality rates. In 1979, however, in addition to the continued fall in operative mortality there was a fall in the proportion of necropsies at which embolism was reported and overall in the proportion of deaths in which embolism was reported by clinical or postmortem examination, or both.
There are many possible explanations for these trends. Throughout this period clinical turnover has accelerated, patients have been mobilised earlier, and discharged earlier. Indeed, we cannot exclude the possibility that some patients may have had fatal embolism after discharge home. Anaesthetic techniques have improved and in particular there has been greater use of local and regional anaesthesia.
Survey in the Edinburgh area in 1978 showed that three out of four general surgeons used routine deep vein thrombosis prophylaxis, of which the commonest was low dose subcutaneous heparin with or without elastic or mechanical compression. Such prophylactic methods were introduced in the early 1970s. It cannot be stated from this study whether prophylaxis has contributed to the fall (as we would like to believe) or whether we surgeons are all busily trying to prevent a disappearing disease.
We should like to acknowledge the help of Dr Rosamund Gruer, community medicine specialist, and Mr D Gordon, research assistant, South Lothian District, in collecting data from the Edinburgh surgical audit. The information on which this study was based was compiled by many Edinburgh surgeons over a span of 20 years. We owe them all our thanks.
All dusts and most gases are potentially harmful. Some are far more dangerous than others, the acute or chronic toxicity being influenced by biological half life, inhaled concentration, and duration of exposure. Also individual sensitivity will vary, especially in the case of those agents causing immunological reactions. Starch comes in the list of 'nuisance particulates" but these are not inert, some cellular response being provoked in the lung if the inhaled concentration is sufficiently great. For this reason, nuisance dusts have a time-weighted eight-hour average inhalation threshold limit value of 10 mg/m3 n at which concentration collagen is not formed to any appreciable extent Gastrointestinal symptoms often accompany oral administration of antibacterial drugs and can occur with all of these drugs. Whether or not they occur probably depends as much on the patient as on the particular drug used; and patients who develop symptoms with one antibiotic are more likely to develop them with others. Nevertheless, some differences in relative frequency have been described and may be used as a rough guide to choosing alternative drugs for patients who develop gastrointestinal symptoms. Diarrhoea is probably due in most patients to qualitative or quantitative changes in bowel flora, though direct toxic effects on the bowel mucosa and immunological factors may play a part'; and it is more common with antibiotics that are incompletely absorbed. Thus the incidence is higher with penicillin V, ampicillin, and tetracycline than with the newer derivatives of ampicillin-for example, amoxycillin and talampicillin2 -cephalexin, co-trimoxazole, and trimethoprim. Anorexia, nausea, and gastric irritation are less common with ampicillin and amoxycillin than with the ampicillin esters (talampicillin, pivampicillin), and may possibly be less common with oral cephalosporins and trimethoprim than with other antibacterials.-LINDA BEELEY, consultant pharmacologist, Birmingham. 261.
